COSM — Cosmos Health Inc.

Nasdaq · Consumer Discretionary · Distributors · CIK 1474167 ·
Last close
$0.24
Market Cap
$15.00M
52W High
$0.45
52W Low
$0.19
ADV30
8,524,792
Next earnings
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 17,927,892 1,381,171 -2,184,179 -2,805,423 62,369,011 514,702 42,542,652
Dec 2025 19,703,160 2,079,344 -11,243,640 -10,145,943 65,477,518 715,674 47,052,889
Sep 2025 17,110,425 2,602,618 -1,818,715 -5,352,890 69,492,758 889,441 46,357,874
Jun 2025 14,745,702 1,163,814 -2,645,319 -2,828,068 61,835,560 655,503 35,603,927

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-9,328,363
Investing CF
$-2,716,749
Financing CF
$13,842,856
CapEx
$-150,414
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-0.36
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-135,972,696
Inventory
$5,650,458
Receivables
$21,037,783
ST Investments
$34,225
EBIT TTM
$-17,883,217
Pretax Income TTM
$-21,132,324
Interest Exp TTM
$3,249,107
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$69,487,176
EBITDA
$-16,500,105
Free Cash Flow
$-11,263,221
Enterprise Value
$30,446,376
Total Cash
$548,927
Total Debt
$17,420,672
Shares Out
62,078,397
Trailing EPS
$-0.66
Book Value
$0.40
ROE
-92.3%
ROA
-18.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 65,271,815 -16,540,819 -19,144,998 65,477,518 47,052,889 -8,447,614
Dec 2024 54,426,402 -15,252,850 -16,183,018 54,311,892 29,778,963 -7,717,034
Dec 2023 53,376,874 -21,831,217 -18,542,654 66,014,811 29,971,783 -15,635,999
Dec 2022 50,347,652 -7,474,036 -13,830,371 68,038,621 28,381,912 -14,870,639

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.07

Peers — same industry

TickerNameMarket CapLastDaily %
UUU UNIVERSAL SAFETY PRODUCTS, INC. $15.35M $5.07
NHTC NATURAL HEALTH TRENDS CORP $15.78M $1.84
MTWO M2i Global, Inc. $15.93M $0.02
IVFH INNOVATIVE FOOD HOLDINGS INC $16.39M $0.30
TLIH Ten-League International Holdings Ltd $13.70M $4.66

News headlines (Yahoo Finance, 1h cache)

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
2026-06-17 19:35 · Yahoo
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
2026-06-17 13:27 · Yahoo
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit
2026-06-15 13:00 · Yahoo
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
2026-06-12 19:33 · Yahoo
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit
2026-06-12 13:29 · Yahoo
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfoli
2026-06-11 19:31 · Yahoo
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
2026-06-11 13:35 · Yahoo
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
2026-06-10 19:32 · Yahoo
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway
2026-06-10 13:00 · Yahoo
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
2026-06-09 19:30 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-06-17 9:15:35 2026-06-16 Terzis Georgios CFO P - Purchase 0.25 168135 42000
2026-06-12 13:22:32 2026-06-11 Siokas Grigorios CEO, 10% P - Purchase 0.21 218447 45000